6301 - 6350 of 7730 Results
Title
Year
- Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes2016RESTRICTEDTitle: Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromesJournal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 4Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12940Citation Count: 10
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases2016RESTRICTEDTitle: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.12813Best OA location URL: https://doi.org/10.7554/elife.12813Citation Count: 803
-
RESTRICTEDTitle: Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working MemoryJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 9Start Page: 2224End Page: 2231Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/npp.2016.14Best OA location URL: https://www.nature.com/articles/npp201614.pdfCitation Count: 23
- Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer Activation2016RESTRICTEDTitle: Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer ActivationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 59Issue #: 3Start Page: 1232End Page: 1238Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01702Citation Count: 13
-
RESTRICTEDTitle: Kinematic A daptive D eep B rain S timulation for R esting T remor in P arkinson's D iseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 426End Page: 428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26482Citation Count: 118
-
RESTRICTEDTitle: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 417End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26483Citation Count: 37
- Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings2016RESTRICTEDTitle: Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy FindingsJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 2Start Page: 250End Page: 256Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26476Best OA location URL: https://europepmc.org/articles/pmc4747813?pdf=renderCitation Count: 70
- Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease2016RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 71
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016RESTRICTEDTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 196
- Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases2016RESTRICTEDTitle: Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control CasesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00507Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00507/pdfCitation Count: 26
- Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study2016RESTRICTEDTitle: Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2015.27Best OA location URL: https://www.nature.com/articles/npjparkd201527.pdfCitation Count: 51
- LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate2016RESTRICTEDTitle: LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rateJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0066-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0066-zCitation Count: 99
- The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR22016RESTRICTEDTitle: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2015.00089Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2015.00089/pdfCitation Count: 46
-
RESTRICTEDTitle: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms10332Best OA location URL: https://www.nature.com/articles/ncomms10332.pdfCitation Count: 82
- Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and Toxicity2016RESTRICTEDTitle: Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and ToxicityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 4Start Page: 931End Page: 942Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b01042Best OA location URL: https://europepmc.org/articles/pmc6300141?pdf=renderCitation Count: 27
- Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease2016RESTRICTEDTitle: Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00500Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00500/pdfCitation Count: 127
- Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases2016RESTRICTEDTitle: Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative DiseasesJournal Name: Annual Review of Pharmacology and ToxicologyPublisher: Annual ReviewsVol: 56Issue #: 1Start Page: 489End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1146/annurev-pharmtox-010715-103548Best OA location URL: https://www.annualreviews.org/doi/pdf/10.1146/annurev-pharmtox-010715-103548Citation Count: 72
-
RESTRICTEDTitle: A Novel Lead Design for Modulation and Sensing of Deep Brain StructuresJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 63Issue #: 1Start Page: 148End Page: 157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tbme.2015.2492921Best OA location URL: https://europepmc.org/articles/pmc4716872?pdf=renderCitation Count: 34
-
RESTRICTEDTitle: Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/7351985Best OA location URL: http://downloads.hindawi.com/journals/pd/2016/7351985.pdfCitation Count: 24
- Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community2016RESTRICTEDTitle: Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the CommunityJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.3098Best OA location URL: https://europepmc.org/articles/pmc4710552?pdf=renderCitation Count: 159
-
RESTRICTEDTitle: Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphismsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: 102End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.11.016Best OA location URL: https://europepmc.org/articles/pmc5954834?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: Autosomal dominant Parkinson's disease caused by SNCA duplicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S1End Page: S6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.007Best OA location URL: https://europepmc.org/articles/pmc4820832?pdf=renderCitation Count: 151
- Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s Disease2016RESTRICTEDTitle: Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 7Issue #: 6Start Page: 745End Page: 745Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2016.0505Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147551Citation Count: 19
-
RESTRICTEDTitle: Biomarkers in Parkinson's disease: Advances and strategiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S106End Page: S110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.048Best OA location URL: https://europepmc.org/articles/pmc5120398?pdf=renderCitation Count: 133
- Deep brain stimulation of the ventromedial prefrontal cortex causes reorganization of neuronal processes and vasculature2016RESTRICTEDTitle: Deep brain stimulation of the ventromedial prefrontal cortex causes reorganization of neuronal processes and vasculatureJournal Name: NeuroImagePublisher: Elsevier BVVol: 125Issue #:Start Page: 422End Page: 427Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.10.049Citation Count: 43
- Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers2016RESTRICTEDTitle: Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 3Issue #: 1Start Page: 51End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.002Best OA location URL: http://www.dadm.alzdem.com/article/S235287291630015X/pdfCitation Count: 63
-
RESTRICTEDTitle: Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba NigeriansJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 49Issue #: 4Start Page: 991End Page: 1003Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-150651Best OA location URL: https://europepmc.org/articles/pmc4822513?pdf=renderCitation Count: 13
-
RESTRICTEDTitle: Genetic susceptibility variants in parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S7End Page: S11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.011Best OA location URL: https://europepmc.org/articles/pmc4662622?pdf=renderCitation Count: 16
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016RESTRICTEDTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 61
-
RESTRICTEDTitle: Immortalized Parkinson's Disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 53
- Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy Cohort2016RESTRICTEDTitle: Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy CohortJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 42Issue #: 1-2Start Page: 106End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000448243Best OA location URL: https://www.karger.com/Article/Pdf/448243Citation Count: 16
- Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease2016RESTRICTEDTitle: Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 7Issue #: 3Start Page: 220End Page: 220Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2015.1110Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147509Citation Count: 13
- Molecular tweezers for lysine and arginine – powerful inhibitors of pathologic protein aggregation2016RESTRICTEDTitle: Molecular tweezers for lysine and arginine – powerful inhibitors of pathologic protein aggregationJournal Name: Chemical CommunicationsPublisher: Royal Society of Chemistry (RSC)Vol: 52Issue #: 76Start Page: 11318End Page: 11334Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/c6cc04640aBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2016/cc/c6cc04640aCitation Count: 116
- Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [18F]FDG PET-CT Study2016RESTRICTEDTitle: Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [18F]FDG PET-CT StudyJournal Name: Case Reports in Neurological MedicinePublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 3Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/8941035Best OA location URL: http://downloads.hindawi.com/journals/crinm/2016/8941035.pdfCitation Count: 2
- MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials2016RESTRICTEDTitle: MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trialsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 37Issue #:Start Page: 26End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.018Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2015.09.018Citation Count: 42
- Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid2016RESTRICTEDTitle: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal FluidJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 1Start Page: 217End Page: 225Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-015-0404-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-015-0404-4.pdfCitation Count: 34
-
RESTRICTEDTitle: Non-radioactive in vitro PINK1 Kinase Assays Using Ubiquitin or Parkin as SubstrateJournal Name: BIO-PROTOCOLPublisher: Bio-Protocol, LLCVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.21769/bioprotoc.1946Best OA location URL: https://europepmc.org/articles/pmc5448420?pdf=renderCitation Count: 5
- Nucleolar PARP-1 Expression Is Decreased in Alzheimer’s Disease: Consequences for Epigenetic Regulation of rDNA and Cognition2016RESTRICTEDTitle: Nucleolar PARP-1 Expression Is Decreased in Alzheimer’s Disease: Consequences for Epigenetic Regulation of rDNA and CognitionJournal Name: Neural PlasticityPublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/8987928Best OA location URL: http://downloads.hindawi.com/journals/np/2016/8987928.pdfCitation Count: 41
-
RESTRICTEDTitle: Optimizing diagnosis in Parkinson's disease: Radionuclide imagingJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S47End Page: S51Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.029Citation Count: 22
-
RESTRICTEDTitle: Parkinson's disease biomarkers program brain imaging repositoryJournal Name: NeuroImagePublisher: Elsevier BVVol: 124Issue #:Start Page: 1120End Page: 1124Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.05.005Best OA location URL: https://europepmc.org/articles/pmc4643422?pdf=renderCitation Count: 14
-
RESTRICTEDTitle: Protein S -Nitrosylation as a Therapeutic Target for Neurodegenerative DiseasesJournal Name: Trends in Pharmacological SciencesPublisher: Elsevier BVVol: 37Issue #: 1Start Page: 73End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tips.2015.10.002Best OA location URL: https://europepmc.org/articles/pmc4698225?pdf=renderCitation Count: 133
- Rapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson’s Disease2016RESTRICTEDTitle: Rapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson’s DiseaseJournal Name: Journal of Alzheimer’s Disease & ParkinsonismPublisher: OMICS Publishing GroupVol: 6Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.4172/2161-0460.1000255Best OA location URL: https://doi.org/10.4172/2161-0460.1000255Citation Count: 0
-
RESTRICTEDTitle: Telemedicine Care for Nursing Home Residents with ParkinsonismJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 64Issue #: 1Start Page: 218End Page: 220Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1111/jgs.13909Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.13909Citation Count: 13
-
RESTRICTEDTitle: The Image and Data Archive at the Laboratory of Neuro ImagingJournal Name: NeuroImagePublisher: Elsevier BVVol: 124Issue #:Start Page: 1080End Page: 1083Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.04.067Best OA location URL: https://europepmc.org/articles/pmc4644502?pdf=renderCitation Count: 47
-
RESTRICTEDTitle: UbFluor: a mechanism-based probe for HECT E3 ligasesJournal Name: Chemical SciencePublisher: Royal Society of Chemistry (RSC)Vol: 7Issue #: 8Start Page: 5587End Page: 5595Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/c6sc01167eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2016/sc/c6sc01167eCitation Count: 22
- Using Tractography to Distinguish SWEDD from Parkinson’s Disease Patients Based on Connectivity2016RESTRICTEDTitle: Using Tractography to Distinguish SWEDD from Parkinson’s Disease Patients Based on ConnectivityJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/8704910Best OA location URL: http://downloads.hindawi.com/journals/pd/2016/8704910.pdfCitation Count: 13
- Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression2016RESTRICTEDTitle: Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progressionJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 37Issue #:Start Page: 209.e1End Page: 209.e7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.014Best OA location URL: https://europepmc.org/articles/pmc4688052?pdf=renderCitation Count: 90
- White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration2016RESTRICTEDTitle: White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegenerationJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 4Issue #: 1Start Page: 18End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.001Best OA location URL: http://www.dadm.alzdem.com/article/S2352872916300197/pdfCitation Count: 72
-
RESTRICTEDTitle: Whole-Exome Sequencing in Familial Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 1Start Page: 68End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.3266Best OA location URL: https://europepmc.org/articles/pmc4946647?pdf=renderCitation Count: 67
- Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology2015RESTRICTEDTitle: Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathologyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 3Start Page: 393End Page: 409Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-015-1526-9Best OA location URL: https://europepmc.org/articles/pmc4754135?pdf=renderCitation Count: 127